Evidence map›Paper›PMID 18560558›Full record

ArticlePloS one2008

Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia.

Jean-Luc Perfettini, Roberta Nardacci, Mehdi Bourouba, Frédéric Subra, Laurent Gros, Claire Séror, Gwenola Manic, Filippo Rosselli, Alessandra Amendola, Peggy Masdehors and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. T-Cell Signaling in HIV-1 Infection.The open virology journal · 2013
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 5 countries.

Jean-Luc PerfettiniINSERM U848, Institut Gustave Roussy, Villejuif, France.
Roberta Nardacci
Mehdi Bourouba
Frédéric Subra
Laurent Gros
Claire Séror
Gwenola Manic
Filippo Rosselli
Alessandra Amendola
Peggy Masdehors
Luciana Chessa
Giuseppe Novelli
David M Ojcius
Jan Konrad Siwicki
Magdalena Chechlinska
Christian Auclair
José R Regueiro
Hugues de Thé
Marie-Lise Gougeon
Mauro Piacentini
Guido Kroemer
Institut Gustave Roussy · FRÉcole Normale Supérieure Paris-Saclay · FRInserm · FRInstitute of Cell Biology and Neurobiology · ITInstitut Pasteur · FRThe Maria Sklodowska-Curie National Research Institute of Oncology · PLGénomes, biologie cellulaire et thérapeutiques · FRIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITSapienza University of Rome · ITUniversidad Complutense de Madrid · ESUniversity of California, Merced · USUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA damage can activate the oncosuppressor protein ataxia telangiectasia mutated (ATM), which phosphorylates the histone H2AX within characteristic DNA damage foci. Here, we show that ATM undergoes an activating phosphorylation in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitro. This was accompanied by aggregation of ATM in discrete nuclear foci that also contained phospho-histone H2AX. DNA damage foci containing phosphorylated ATM and H2AX were detectable in syncytia present in the brain or lymph nodes from patients with HIV-1 infection, as well as in a fraction of blood leukocytes, correlating with viral status. Knockdown of ATM or of its obligate activating factor NBS1 (Nijmegen breakage syndrome 1 protein), as well as pharmacological inhibition of ATM with KU-55933, inhibited H2AX phosphorylation and prevented Env-elicited syncytia from undergoing apoptosis. ATM was found indispensable for the activation of MAP kinase p38, which catalyzes the activating phosphorylation of p53 on serine 46, thereby causing p53 dependent apoptosis. Both wild type HIV-1 and an HIV-1 mutant lacking integrase activity induced syncytial apoptosis, which could be suppressed by inhibiting ATM. HIV-1-infected T lymphoblasts from patients with inactivating ATM or NBS1 mutations also exhibited reduced syncytial apoptosis. Altogether these results indicate that apoptosis induced by a fusogenic HIV-1 Env follows a pro-apoptotic pathway involving the sequential activation of ATM, p38MAPK and p53.

Indexed as

DNA DamageAdultApoptosisAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsDNA-Binding ProteinsFemaleGiant CellsHeLa CellsHistonesHIV-1HumansImmunohistochemistryMalep38 Mitogen-Activated Protein KinasesPhosphorylationAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsHistonesp38 Mitogen-Activated Protein KinasesProtein Serine-Threonine KinasesTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID18560558
PMCPMC2423469
OpenAlexW2076384202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.